Results 71 to 80 of about 5,535 (166)

Spotlight on sudden arrhythmic death syndrome

open access: yesResearch Reports in Clinical Cardiology, 2019
David Yuan,1 Hariharan Raju1,2 1Cardiology Department, Concord Repatriation General Hospital, Sydney, Australia; 2Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, AustraliaCorrespondence: Hariharan RajuCardiology Department,
Yuan D, Raju H
doaj  

Longest survivor of pulmonary atresia with ventricular septal defect without surgical intervention

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1499-1507, April 2025.
Sang Zhou   +5 more
wiley   +1 more source

Inflammation and genetics in myo‐pericardial diseases: Insights from the Italian Study Group on Cardiomyopathies and Pericardial Diseases

open access: yesESC Heart Failure, EarlyView.
Proposed management of myo‐pericardial diseases. A systematic interdisciplinary approach to myo‐pericardial disease is essential to reach a correct diagnosis, starting from multiparametric characterization including EKG, echocardiography with GLS, laboratory exams and CMR or, in case of electric or haemodynamic instability, EMB.
Marco Merlo   +18 more
wiley   +1 more source

Risk of sudden cardiac death

open access: yesARYA Atherosclerosis, 2013
BACKGROUND: The aim of this study was to determine characteristics of patients with sudden cardiac arrest (SCA) and/or sudden cardiac death (SCD). We need an effective risk stratification method for SCD in patients without low left ventricular ejection ...
Roxana Sadeghi   +3 more
doaj  

Predicting acute decompensated heart failure using circadian markers from heart rate time series

open access: yesESC Heart Failure, EarlyView.
Circadian metrics—amplitude, mesor, and acrophase—derived from a wrist‐worn heart rate monitor can predict acute decompensated heart failure (ADHF) up to 21 days before onset. In 65 post‐ADHF patients, an LSTM model achieved 74% sensitivity, and 73% specificity trained on 21‐day sequences. These findings support circadian rhythm analysis as a promising
Valerie A. A. van Es   +9 more
wiley   +1 more source

Cardiac sarcoidosis causing sudden death

open access: yesIndian Journal of Pathology and Microbiology, 2009
Sarcoidosis is a systemic disease of young adults. Cardiac involvement is rarely diagnosed clinically. In most cases it presents with arrhythmias and conduction disorders.
Suranagi Vijayalaxmi   +2 more
doaj  

The story of Christian Eriksen. To close the loop

open access: yesEmergency Care Journal
Dear Editor, On June 12, 2021, Christian Eriksen's life took an unexpected turn when he suffered a cardiac arrest during a match.1Thanks to the swift and skilled actions of medical personnel who administered Cardiopulmonary Resuscitation (CPR), Eriksen ...
Gian Domenico Giusti, Nicola Ramacciati
doaj   +1 more source

Sudden Cardiac Death Risk Stratification and Prevention in Chagas Disease: A Non-systematic Review of the Literature

open access: yesArrhythmia & Electrophysiology Review, 2020
Roberto Keegan   +2 more
doaj   +1 more source

Poor cardiovascular outcomes of underweight abdominal obesity in the entire population of newly diagnosed heart failure

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Body mass index (BMI) has been widely used as a simple tool for predicting cardiovascular risk. Here we aimed to analyse the distribution and cardiovascular outcomes according to BMI and waist circumference (WC) of the newly diagnosed heart failure (HF) patients in the entire population of the Republic of Korea for 10 years.
Joongmin Kim   +8 more
wiley   +1 more source

Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA‐MI

open access: yesESC Heart Failure, EarlyView.
We investigated cardiometabolic outcomes in patients treated with dapagliflozin 10 mg once daily or placebo after acute myocardial infarction according to LVEF at randomisation in the registry‐based, randomised DAPA‐MI trial. Regardless of baseline LVEF, dapagliflozin resulted in significant cardiometabolic benefits versus placebo, suggesting that ...
David Erlinge   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy